A. Sanz

发表

Toxic anterior segment syndrome (TASS): studying an outbreak

M. S. Carricas, G. S. Bellmunt, L. Lasanta, 2008 .

A Multi‑Center, Open‑Label, Single‑Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

P. Kralickova, R. Kobbe, J. Douglass, 2022, Journal of Clinical Immunology.

Subcutaneous anti-COVID-19 hyperimmune immunoglobulin for prevention of disease in asymptomatic individuals with SARS-CoV-2 infection: a double-blind, placebo-controlled, randomised clinical trial

Q. Bassat, B. Clotet, A. Jorge, 2023, eClinicalMedicine.

Factors associated with adherence in HIV patients

A. Velasco, A. Sanz, E. A. Esteban, 2009 .